| R21082480 |
A922500 |
A 922500 is an effective, selective and orally available dgat-1 inhibitor with a
|
| R21082481 |
BI-3812 |
Bi-3812 is a highly effective inhibitor of BCL6, which can inhibit the BTB domai
|
| R21082482 |
EN4 |
EN4 MYC inhibitor is a covalent ligand that targets cysteine 171 (C171) of MYC.
|
| R21082483 |
pamiparib |
Pamiparib is a PARP inhibitor that can be used to treat a variety of cancers, in
|
| R21082484 |
U0126 |
U0126 is a potent, non-ATP-competitive, selective inhibitor of MEK1 and MEK2 wit
|
| R21082485 |
TPX-0022 |
Csf1r-in-2 (Compound 5) is an oral effective inhibitor of SRC, MET and C-FMS, wi
|
| R21082486 |
AGI1067;Succinobucol |
Succinobucol is a phenolic antioxidant that has anti-inflammatory and anti-plate
|
| R21082487 |
CBP-IN-1 |
Cbp-in-1 is a highly effective p300/CBP bromine domain inhibitor.
|
| R21082488 |
Lats-IN-1 |
Lats-in-1 is a potent and ATP-competitive inhibitor of Lats1 and Lats2 kinases.
|
| R21082489 |
BMS-986177 |
Milvexian, also known as BMS-986177, is a blood coagulation factor XIa inhibitor
|
| R21082490 |
1808258-86-7 |
|
| R21082491 |
LSN3346149 |
|
| R21082492 |
IA-14069 |
|
| R21082493 |
ASTX-029 |
ASTX029 is a synthetic small molecule inhibitor of extracellular signal-regulate
|
| R21087001 |
1-(hydroxymethyl)cyclopropanecarbonitrile |
|
| R21087002 |
7-bromo-2,4-dichloroquinazoline |
|
| R21087003 |
2-Cyano-6-methoxybenzothiazole |
|
| R21087004 |
2-bromo-1-(bromomethyl)-4-nitrobenzene |
|
| R21087005 |
1-ETHYNYLCYCLOHEXENE |
|
| R21087006 |
3,4-Dimethyl-1H-pyrazole-5-carboxylic acid |
|
| R21087007 |
6-bromoisoquinolin-3-amine |
|
| R21087008 |
5-Bromo-4-methylnicotinonitrile |
|
| R21087009 |
N-BOC PRROLIDIN-2-OL |
|
| R21087010 |
methyl 4-(bromomethyl)-2-methylbenzoate |
|
| R21087011 |
1-BROMOMETHYL-ISOQUINOLINE |
|